The Effect of Glibenclamide on the Functional Activity of К_ATP Channels of Cerebral Arteries in Rats with Streptozotocin Diabetes Mellitus

BACKGROUND: In the treatment of diabetes mellitus (DM) for a persistent reduction in blood glucose levels it was widely used glibenclamide — a KATP channels blocker. However, its effects on cerebral circulation have been studied very little. A decrease in the functional activity of KATP channels due to their blocking by glibenclamide against the background of developed endothelial dysfunction may lead to impaired cerebral circulation (especially at the microcirculatory level) and promote remodeling of the vascular network.

AIM: To evaluate the effect of glibenclamide on the reactivity of cerebral arteries in rats with streptozotocin-induced diabetes mellitus (STZ-T2DM).

TASKS: 1. To study changes in the functional state of KATP channels of pial arteries in STZ-T2DM. 2. To evaluate the effect of glibenclamide on the participation of KATP channels in the formation of basal tone and endothelium-dependent dilatation of pial arteries.

MATERIALS AND METHODS: The study was performed on 54 male Sprague Dawley rats. Streptozotocin-induced diabetes mellitus (STZ-T2DM) was modeled by keeping animals on a high-fat diet and administering streptozocin (35 mg/kg). Using an installation for intravital study of pial vessels reactivity, 3 months from the beginning of the experiment, the diameter of the arteries was measured when the brain surface was irrigated with Krebs-Henseleit solution, acetylcholine, glibenclamide, pinacidil and acetylcholine against the background of the action of glibenclamide or pinacidil.

RESULTS: With modeling STZ-T2DM, rats developed glucose tolerance and insulin resistance. Compared to control animals, body weight was 1,3 times higher, the percentage of visceral fat was 3 times higher, and the blood glucose level was 3,2 times higher. It was shown that in STZ-T2DM the number of pial artery constrictions under the action of glibenclamide decreased by 1,3 — 1,9 times compared to intact rats. Glibenclamide did not block endothelium-dependent dilation.

CONCLUSION: In rats with streptozotocin diabetes, KATP channels take part in the formation of the basal tone of the pial arteries, but the contribution of these channels is reduced on average by 1.5 times compared to healthy rats.

The use of glibenclamide in STZ-T2DM does not affect endothelium-dependent dilatation of cerebral arteries.

1. Chernyshova TE, Styazhkina SN. Glibenclamide: a place in modern therapy of type 2 diabetes mellitus // Effective pharmacotherapy. 2023;19(31):18-23 (in Russ.). doi: https://doi.org/10.33978/2307-3586-2023-19-31-18-23

2. Faraji A, Tahamtani L, Maharlouei N, et al. Effects of oral glibenclamide versus subcutaneous insulin on perinatal outcome of patients with gestational diabetes mellitus: A randomized clinical trial. Asadi N.Obstet Med. 2023:16(2):98-103. doi: https://doi.org/10.1177/1753495X221100167

3. Sun D, Wang J, Toan S, et al. Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance. Angiogenesis. 2022;18. doi: https://doi.org/10.1007/s10456-022-09835-8

4. Price JM, Chi X, Hellermann G, Sutton ET. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res. 2001;23(5):506-12. doi: https://doi.org/10.1179/016164101101198758

5. White MF, Kahn CR. Insulin action at molecular level — 100 years of progress. Mol Metab. 2021;52. doi: https://doi.org/101304.10.1016/j.molmet.2021.101304

6. Ahmad MN, Farah AI, Al-Qirim TM. The cardiovascular complications of diabetes: a striking link through protein glycation. Rom J Intern Med. 2020;58(4):188-198. doi: https://doi.org/10.2478/rjim-2020-0021

7. Balabolkin MI. Rol’ glikirovaniya belkov, okislitel’nogo stressa v patogeneze sosudistykh oslozhneniy pri sakharnom diabete. Diabetes mellitus. 2002;5(4):8-16 (in Russ.). doi: https://doi.org/10.14341/DM200248-16

8. Cao X, Xia Y, Zeng M, et al. Caffeic acid inhibits the formation of advanced glycation end products (AGEs) and mitigates the AGEs-induced oxidative stress and inflammation reaction in human umbilical vein endothelial cells (HUVECs). Chem Biodivers. 2019;16(10):e1900174. doi: https://doi.org/10.1002/cbdv.201900174

9. Nichols CG, York NW, Remedi MS. ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm? Diabetes. 2022;71(3):367-375. doi: https://doi.org/10.2337/db21-0755

10. Szeto V, Chen NH, Sun HS, Feng ZP. The role of KATP channels in cerebral ischemic stroke and diabetes. Acta Pharmacol Sin. 2018;39(5):683-694. doi: https://doi.org/10.1038/aps.2018.10

11. Syed AU, Koide M, Brayden JE, Wellman G. Tonic regulation of middle meningeal artery diameter by ATP-sensitive potassium channels. Journal of Cerebral Blood Flow and Metabolism. 2019;39(4):670-679. doi: https://doi.org/10.1177/0271678X17749392

12. Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacological Res. 2005;52(4):313-320. doi: https//doi.org/10.1016/j.phrs.2005.05.004

13. Spasov AF, Babkov DA, Muleeva DR, Mayka OYu. Modeling streptozotocin-induced type 2 diabetes mellitus in rats on a high-fat diet // Bulletin of the VolgSMU. 2017;1(61):30-31(in Russ).

14. Balog M, Ivic V, Scitovski R, et al. A mathematical model reveals sex-specific changes in glucose and insulin tolerance during rat puberty and maturation. Croat Med J. 2020;61(2):107-118. doi: https://doi.org/10.3325/cmj.2020.61.107

15. Yakimovich IY, Borodin DA, Podrezov IK, et al. White adipose tissue morphometric characteristics in hi-fat diet rats. Modern problems of science and education. 2015;5 (In Russ.).

16. Gorshkova OP, Sokolova IB. H2S-mediated dilation of pial arteries in rats of different ages: contribution of КАТФ and BKCa cannels. Journal of Evolutionary Biochemistry and Physiology. 2023;59(4):1414-1425. doi: https://doi.org/10.1134/S1234567823040328

17. Tseng CH. Dementia risk in type 2 diabetes patients: acarbose use and its joint effects with metformin and pioglitazone. Aging Dis. 2020;11(3):658-667. doi: https://doi.org/10.14336/AD.2019.0621

18. Arshad NA, Lin TS, Yahaya MF. Metabolic syndrome and its effect on the brain: possible mechanism. CNS Neurol Disord Drug Targets. 2018;17(8):595-603. doi: https://doi.org/10.2174/1871527317666180724143258

19. Sancho M, Fletcher J, Welsh DG. Inward rectifier potassium channels: membrane lipid-dependent mechanosensitive gates in brain vascular cells. Front Cardiovasc Med. 2022;9:869481. doi: https://doi.org/10.3389/fcvm.2022.869481

20. Zeidner G, Sadja R, Reuveny E. Redox-dependent gating of G protein-coupled inwardly rectifying K+ channels. J Biol Chem. 2001;76(38):35564-70. doi: https://doi.org/10.1074/jbc.M105189200

21. Gusakova SV, Smagliy LV, Birulina YG, et al. Molecular mechanisms of action og gas transmitters NO, CO and H2S in smooth muscle cells and effect of NO-generating compounds (nitrates and nitrites) on average life expectancy. Advances in physiological sciences. 2017;48(1):24-52 (in Russ.).

22. Weber S, Patel R, Lutsep H. Cerebral amyloid angiopathy: diagnosis and potential therapies. Expert Rev Neurother. 2018;18(6):503-513. doi: https://doi.org/10.1080/14737175.2018.1480938

23. Kakoty V, Kc S, Kumari S, et al. Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation. Inflammopharmacology. 2023;23. doi: https://doi.org/10.1007/s10787-023-01187-z

24. Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, et al. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30-42. doi: https://doi.org/10.1038/s41582-019-0281-2

25. Maqoud F, Scala R, Hoxha M, et al. ATP-sensitive potassium channel subunits in neuroinflammation: novel drug targets in neurodegenerative disorders. CNS Neurol Disord Drug Targets. 2022;21(2):130-149. doi: https://doi.org/10.2174/1871527320666210119095626

26. Nuñez-Diaz C, Pocevičiūtė D, Schultz N, et al. Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide. Mol Brain. 2023;16(1):25. doi: https://doi.org/10.1186/s13041-023-01013-1

27. Sokolova IB. Invovement of inducible nitric oxide synthase in pial arterial tone formation under metabolic disorders and streptozotocin-induced diabetes in rats kept on a high-fat diet. J of Evolutionary Biochemistry and Physiology. 2022;58(5):1482-1490. doi: https://doi.org/10.1134/S0022093022050180